ASAP Act

Legislation to improve care at the end of life; including H.R. 4313 / S. 2237; PCHETA (S. 2287/H.R.4425); Improving Access to Advance Care Planning Act (S.2865); Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130); Medicare Advance Planning (MAP) for Care Act (S. 3473; Compassionate Care Act (H.R.10013/S.5219); the Stop Corporate Takeovers of Physicians Act of 2026 (H.R. 10444/S.5419).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to improve care at the end of life; including H.R. 4313 / S. 2237; PCHETA (S. 2287/H.R.4425); Improving Access to Advance Care Planning Act (S.2865); Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130); Medicare Advance Planning (MAP) for Care Act (S. 3473); Compassionate Care Act (H.R.10013/S.5219); the Stop Corporate Takeovers of Physicians Act of 2026 (H.R. 10444/S.5419)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues related to Medicare and Medicaid, including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; enter for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act

Client expense: $450,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)

Client expense: Not reported · Firm income: $110,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)

Client expense: Not reported · Firm income: $110,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions regarding drug pricing and supply chain issues; rare diseases; Alzheimer's policy, screening and diagnosis, dementia care; ALS, Lupus and Kidney related policy issues. Issues related to patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues, no specific bill numbers. Engage on public policy associated with orphan drug act, rare disease research, screening, detection and patient access for rare therapies. Public Policy efforts around Alzheimer's screening and diagnosis Public policy around patients access and affordability for necessary and life-saving medications prescribed by their doctors. S.864, HELP Copays Act, to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-share H.R.6130/S.3267, ASAP Act, to provide coverage for blood based biomarker Alzheimer's disease diagnosis H.R.3747, AADAPT Act, to provide for training for primary care for screening, detection and diagnosis for Alzheimer's disease H.R.1262, Mikaela Naylon Give Kids a Chance Act, reauthorization of FDA Pediatric-Priority Review Voucher Program

Client expense: $880,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3501, S. 1799 - a bill to amend title XVIII of the Social Security Act to direct CMS to include certain standardized tests for cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination; H.R. 5371 - FY2026 Continuing Appropriations and Extensions Act; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; H.R. 6130, S. 3267 - ASAP Act; H.R. 9418 - Access to Innovative Treatments Act of 2026; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4494 - Durbin Cures Act; Issues related to the Affordable Care Act, Medicaid and comprehensive healthcare; Issues related to implementation of PL-119-21; Issues related to coverage for biomarker testing; H.R. 9823 - The Alzheimer's Early Detection Act

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of

H.R. 1, One Big Beautiful Bill Act, implementation and patient access issues. S. 1816/H.R. 3514, Improving Seniors' Timely Access to Care Act. S. 1717/H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act. H.R. 3521/S. 4440, Clinical Trial Modernization Act. S. 2903/H.R. 5509, Safe Step Act. FY 2027 Labor, HHS, Education appropriations for programs affecting people with chronic diseases and disabilities. S. 494/ H.R.1189 National Plan for Epilepsy Act Senate Finance Committee RFI on Drug Pricing and Health Coverage H.R. 9599 SECURE 340B Act Discussion Draft - 340B Drug Pricing Integrity and Affordability for Patients Act S. 5244 SUSTAIN 340B Act H.R.7352/S. 4875 PASTEUR Act S.3267/H.R. 6130 ASAP Act

Client expense: $21,227 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.3251/S 4440 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement -Update CMS Long stay antipsychotic Quality measure -Update FDA Antipsychotic black box warning -Funding for NIH (HR 9260) -PASTEUR Act (HR 7352/S 4975) -Biosimilar Access and Affordability Act (HR10628/S5571) -CMS Fixed Dose Combination Therapies proposed policy -OMB Proposed Uniform Guidance on Federal Grantmaking (HR 6500) -Alzheimer's Early Detection Act (HR 9823) -CMS reporting requirements for Medicare Prescription Payment Program (HR 9260) -CMS Trans Catheter Aortic Valve Replacement NCD proposal

Client expense: $65,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General Parkinsons disease information, including disease burden, symptoms, health coverage, health care costs, environmental risk factors, and access to care for underserved communities. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy related to the development and execution of the National Parkinsons Project (NPP), interagency coordination, advisory council establishment, reporting requirements, and congressional oversight, as well as appropriations to support implementation activities. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)) and support for related congressional appropriations requests and communications. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy in appropriations to re-establish and expand Udall Centers, related report language, and coordination with the National Parkinsons Project. Advanced Research Projects Agency for Health (ARPA-H) and neurodegenerative disease research, including advocacy for report language directing prioritization of high-risk, high-reward research on Parkinsons disease and related neurodegenerative conditions. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research, including advocacy for report language to expand funding eligibility to Parkinsons disease and related dementias and support research on the intersection of Parkinsons disease and dementia. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support data collection and surveillance of Parkinsons disease and related conditions. Department of Health and Human Services (HHS) coordination on environmental risk factors and neurodegenerative disease prevention, including advocacy for report language and funding to support interagency coordination and research on toxic exposures and Parkinsons disease and related conditions. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for cosponsorship and provisions supporting research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. Environmental risk factors and Parkinsons disease, including advocacy related to pesticide exposure and paraquat, and support for Environmental Protection Agency (EPA) action to reassess and restrict or ban paraquat due to links to Parkinsons disease. The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to early detection of Alzheimers disease and related dementias and access to diagnostic tools. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Essential Caregivers Act of 2026 (H.R. 9641), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid.

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

Medicare and Medicaid coverage, access, and affordability of treatments for Parkinsons disease and other chronic conditions, including beneficiary access to care, prescription drug coverage, and utilization management policies. The Alleviating Barriers for Caregivers (ABC) Act (H.R. 2491 / S. 1227), including advocacy related to simplifying Medicare and Social Security processes and improving access to benefits for caregivers and individuals with chronic conditions. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Essential Caregivers Act of 2026 (H.R. 9641), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to Medicare coverage of blood-based biomarker tests for early detection of Alzheimers disease and related dementias. Centers for Medicare & Medicaid Services (CMS) policies, including advocacy related to Medicare Part D and Medicare Advantage, prescription drug affordability, formulary design, utilization management, and beneficiary protections.

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models); drug pricing; H.R.6130, Alzheimers Screening and Prevention (ASAP) Act of 2025.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/S. 1410 - Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care in the VA health system without requiring a referral. H.R. 6238/S. 3254 - NIH IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839/S.502 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transition to primary care, care navigation and workforce support. H.R. 9090/S. 4503 - Advancing Menopause Care and Mid-Life Womens Health Act All provisions This bill expands federal research, training, awareness and education efforts around menopause.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Financial Services and General Government Appropriations Bill: HR 8495 CONNECT for Health Act: HR 4206 / S 1261 Alzheimers Screening and Prevention Act of 2025: HR 6130 / S 3267 Credit for Caring Act of 2025: HR 2036 / S 925 Lowering Costs for Caregivers Act: HR 138 / S 1565 Geralds Law Act: HR 7199 Bringing Oversight to Washington and Safety to Every Resident Act: HR 1089 / S 440 (oppose) Palliative Care and Hospice Education and Training Act: HR 4425 / S 2287 Hospice CARE Act of 2026: HR 7966 / S 4118 Expanding Access to Palliative Care Act: S 1935 Legacy Act of 2025: HR 5861 MAP for Care Act: HR 6721 / S 3473 DC Home Rule Act amendment (the bill has no title; it would block DC from permitting medical aid in dying): HR 7196 Patient Access to End of Life Care Act: no number yet (pending introduction) Compassionate Care Act: no number yet (pending introduction) Health Equity and Accountability Act: no number yet (pending introduction) VA CAREERS Act: no number yet (pending introduction)

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for reauthorization of geriatrics workforce enhancement and academic career award programs (HR 4262, to reauthorize programs related to health professions education, and for other purposes, Energy & Commerce Committee draft for Title VII programs reauthorization; S.4110, EMPOWER for Health Act; and S.2699, Geriatrics Workforce Improvement Act). Support for research programs at the National Institute on Aging on drivers of chronic conditions, older adult medical complexity and Alzheimer's disease and related dementias. Support for amendments to S.1799/HR 3501, "Concentrating on High-Value Alzheimers Needs to Get to an End" legislation to provide for shared decision making, care planning and services, and primary care quality measures in connection with cognitive screening of Medicare beneficiaries; and monitoring of H.R. 6130, the Alzheimers Screening and Prevention (ASAP) Act of 2025.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for Medicare physician payment reform, including H.R.879, the Medicare Patient Access and Practice Stabilization Act of 2025 and H.R. 8163, Provider Reimbursement Stability Act (H.R. 8163); Support for amendments to S. 1799/HR 3501, "Concentrating on High-Value Alzheimers Needs to Get to an End" to provide for shared decision-making, care planning and services, and primary care quality measures in connection with cognitive screening for Medicare beneficiaries; and monitoring of H.R. 6130, the Alzheimers Screening and Prevention (ASAP) Act of 2025.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; H.R. 9117, the Clear Healthcare Expense Cost Knowledge (CHECK) Act, provisions relating to administrative service provider price transparency and itemized patient billing; S. 3097, the Health Information Privacy Reform Act, provision relating to privacy of health data; H.R. 8500, the Timely Access to Coverage Decisions Act, provisions relating to establishment of standards for Medicare local coverage decisions; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; H.R. 6130/S. 3267, the Alzheimers Screening and Prevention (ASAP) Act, provisions relating to Medicare coverage of blood-based dementia screening tests; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to amending the Public Health Service Act to address the shortage of medical laboratory personnel; Federal policy relating to prior authorization and oversight of laboratory benefit managers; Federal policy relating to access to mandatory code sets for administrative transactions; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

PREEMIE Reauthorization Act, HR 1197, S 1562; Preventing Maternal Deaths Reauthorization Act, HR 1909, S 2621; Alzheimer's Screening and Prevention Act, HR 6130, S. 3267; Accelerating Access to Dementia and Alzheimer's Provider Training Act, HR 3747, S. 4036

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6130/S. 3267 - Alzheimer's Screening And Prevention (ASAP) Act

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act H.R. 4093, S. 3848, Apples to Apples Comparison Act H.R. 4731/S. 2439, Resident Physician Shortage Reduction Act H.R. 6010/S. 1105, No UPCODE Act H.R. 6130/ S. 3267, Alzheimers Screening and Prevention Act U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) U.S Department of Health and Human Services, Centers for Medicare & Medicaid ServicesAdvance Notice of Methodological Changes for Calendar Year (CY) 2027 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (CMS-2026-0034) U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity (HTI-5) Proposed Rule (RIN 0955-AA09) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care (RIN 0955-AA13)

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act H.R. 4093, S. 3848, Apples to Apples Comparison Act H.R. 4731/S. 2439, Resident Physician Shortage Reduction Act H.R. 6010/S. 1105, No UPCODE Act H.R. 6130/ S. 3267, Alzheimers Screening and Prevention Act U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) U.S Department of Health and Human Services, Centers for Medicare & Medicaid ServicesAdvance Notice of Methodological Changes for Calendar Year (CY) 2027 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (CMS-2026-0034) U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity (HTI-5) Proposed Rule (RIN 0955-AA09) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Technology Policy Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care (RIN 0955-AA13)

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare and Medicaid reimbursement; H.R.6130 Alzheimer's Screening and Prevention Act, Alzheimer's screening

Client expense: $350,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions regarding drug pricing and supply chain issues; rare diseases; Alzheimer's policy, screening and diagnosis, dementia care; ALS, Lupus and Kidney related policy issues. Issues related to patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues, no specific bill numbers. Engage on public policy associated with orphan drug act, rare disease research, screening, detection and patient access for rare therapies. Public Policy efforts around Alzheimer's screening and diagnosis Public policy around patients access and affordability for necessary and life-saving medications prescribed by their doctors. S.864, HELP Copays Act, to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-share H.R.6130/S.3267, ASAP Act, to provide coverage for blood based biomarker Alzheimer's disease diagnosis H.R.3747, AADAPT Act, to provide for training for primary care for screening, detection and diagnosis for Alzheimer's disease Issues related to the Food and Drug Administration including PDUFA, druga reviews, approval pathways, and clinical trials H.R.1262, Mikaela Naylon Give Kids a Chance Act, reauthorization of FDA Pediatric-Priority Review Voucher Program Postpartum Depression public policy on screening, detection and education

Client expense: $1,060,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Lobbying Issues Description: Budget and appropriations for public health, disease and injury prevention, including obesity and related diseases; pandemics and emerging infectious diseases; physical activity; public health preparedness; nutrition programs; environmental health; health equity; community-based public health interventions; public health infrastructure and workforce; maternal health; substance misuse/behavioral health issues; vaccines and immunizations; antimicrobial resistance; public health data modernization; global health. Specific Legislation: 1.Preventing Adverse Childhood Experiences Act (Not yet introduced) 2.Mental Health Services for Students Act (H.R.5557) 3.Helping Kids Cope Act (Not yet introduced) 4.Advancing Student Services in Schools Today Act (S.2050) 5.Pursuing Equity in Mental Health Act (H.R.2904/S.1448) 6.RISE from Trauma Act (S.3461/H.R.6625) 7.Better Mental Health Care for Americans Act (Not yet introduced) 8.Reentry Act (H.R. 2586) 9.FY 2027 Labor, HHS, Education and Related Agencies Appropriations 10.FY 2027 Agriculture, Rural Development and Drug Administration Appropriations, provisions related to nutrition 11.Farm, Food, and National Security Act of 2026 12.Improving Social Determinants of Health Act (Not yet introduced) 13.The UNDERSTAND Act (Not yet introduced) 14.The TRUTH in Labeling Act (Not yet introduced) 15.Child Nutrition Reauthorization 16.Promoting Physical Activity for Americans Act (H.R. 6121) 17.Momnibus Act (H.R.7973) 18.Older Americans Act Reauthorization (S.2120) 19.Protecting the Health of Americas Older Adults Act (Not yet introduced) 20.Pandemic and All-Hazards Preparedness Act Reauthorization (Not yet introduced) 21.Public Health Infrastructure Saves Lives Act (Not yet introduced) 22.The Support for Patients and Communities Reauthorization Act (H.R. 2483/S.2121) 23.The PEER Support Act (H.R.2741/S.1329) 24.The Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act (S.931/ H.R.2509) 25.The 9-8-8 Implementation Act (Not yet introduced) 26.Local 988 Response Act (Not yet introduced) 27.Lead-Safe Housing for Kids Act (Not yet introduced) 28.The Kid PROOF Act (H.R.6396) 29.EARLY Minds Act (S.779/H.R.1735) 30.Campus Prevention and Recovery Services for Students Act (H.R.7019) 31.Stabilization to Prevent (STOP) Suicide Act (H.R.8124) 32.Womens Heart Health Expansion Act of 2026 (S.3944) 33.Childhood Diabetes Reduction Act (Not yet introduced) 34.Raising Awareness for Youth Suicide Prevention (RAYS) Act (H.R.7092/S.4061) 35.Campus Lifeline Act of 2026 (H.R.8657) 36.Improving Mental Health Access for Students Act (S.1924/H.R.3624) 37.9-8-8 CONNECT Act (H.R.8122) 38.Improving Non-medical Drivers of Health Act (Not yet introduced) 39.Alzheimers Screening and Prevention Act (H.R.6130) 40.Tech to Save Moms Act (S. 958/H.R. 8317) 41.BUILD America 250 Act (H.R.8870)/Surface transportation reauthorization House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, White House Domestic Policy Council, HHS, CDC, FDA, USDA, OMB, HRSA, SAMHSA, and Federal Communications Commission (FCC).

Client expense: $41,945 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act H.R. 6130 - Alzheimers Screening and Prevention Act of 2025 Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General Medicare and Medicaid including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; Center for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act

Client expense: $790,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to improve care at the end of life; including H.R. 4313 / S. 2237; PCHETA (S. 2287/H.R.4425); Improving Access to Advance Care Planning Act (S.2865); Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130); Medicare Advance Planning (MAP) for Care Act (S. 3473).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation to improve care at the end of life; including H.R. 4313 / S. 2237; PCHETA (S. 2287/H.R.4425); Improving Access to Advance Care Planning Act (S.2865); Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130); Medicare Advance Planning (MAP) for Care Act (S. 3473).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3501, S. 1799 - a bill to amend title XVIII of the Social Security Act to direct CMS to include certain standardized tests for cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination; H.R. 5371 - FY2026 Continuing Appropriations and Extensions Act; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; H.R. 6130, S. 3267 - ASAP Act; H.R. 9418 - Access to Innovative Treatments Act of 2026; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Durbin Cures Act; Issues related to the Affordable Care Act, Medicaid and comprehensive healthcare; Issues related to implementation of PL-119-21; Issues related to coverage for biomarker testing

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of

General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)

Client expense: Not reported · Firm income: $80,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)

General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)

Client expense: Not reported · Firm income: $80,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)

H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/S. 1410 - Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care in the VA health system without requiring a referral. H.R. 6238/S. 3254 - NIH IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transition to primary care, care navigation and workforce support. H.R. 9090/S. 4503 - Advancing Menopause Care and Mid-Life Womens Health Act All provisions This bill expands federal research, training, awareness and education efforts around menopause.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

PREEMIE Reauthorization Act, HR 1197, S 1562; Preventing Maternal Deaths Reauthorization Act, HR 1909, S 2621; Alzheimer's Screening and Prevention Act, HR 6130, S. 3267; Accelerating Access to Dementia and Alzheimer's Provider Training Act, HR 3747, S. 4036

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid coverage, access, and affordability of treatments for Parkinsons disease and other chronic conditions, including beneficiary access to care, prescription drug coverage, and utilization management policies. The Alleviating Barriers for Caregivers (ABC) Act (H.R. 2491 / S. 1227), including advocacy related to simplifying Medicare and Social Security processes and improving access to benefits for caregivers and individuals with chronic conditions. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to Medicare coverage of blood-based biomarker tests for early detection of Alzheimers disease and related dementias. Centers for Medicare & Medicaid Services (CMS) policies, including advocacy related to Medicare Part D and Medicare Advantage, prescription drug affordability, formulary design, utilization management, and beneficiary protections.

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General Parkinsons disease information, including disease burden, symptoms, health coverage, health care costs, environmental risk factors, and access to care for underserved communities. Implementation of the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinsons Act (Public Law No. 118-66), including advocacy related to the development and execution of the National Parkinsons Project (NPP), interagency coordination, advisory council establishment, reporting requirements, and congressional oversight, as well as appropriations to support implementation activities. Federal funding for Parkinsons disease and neurodegenerative disease research at the National Institutes of Health (NIH), including advocacy for increased appropriations across NIH institutes (including the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA)) and support for related congressional appropriations requests and communications. National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinsons Disease Research, including advocacy in appropriations to re-establish and expand Udall Centers, related report language, and coordination with the National Parkinsons Project. Advanced Research Projects Agency for Health (ARPA-H) and neurodegenerative disease research, including advocacy for report language directing prioritization of high-risk, high-reward research on Parkinsons disease and related neurodegenerative conditions. Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) research, including advocacy for report language to expand funding eligibility to Parkinsons disease and related dementias and support research on the intersection of Parkinsons disease and dementia. Centers for Disease Control and Prevention (CDC) National Neurological Conditions Surveillance System (NNCSS), including advocacy for continued appropriations to support data collection and surveillance of Parkinsons disease and related conditions. Department of Health and Human Services (HHS) coordination on environmental risk factors and neurodegenerative disease prevention, including advocacy for report language and funding to support interagency coordination and research on toxic exposures and Parkinsons disease and related conditions. The Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779), including advocacy for cosponsorship and provisions supporting research on environmental risk factors and toxic exposures linked to neurodegenerative diseases. Environmental risk factors and Parkinsons disease, including advocacy related to pesticide exposure and paraquat, and support for Environmental Protection Agency (EPA) action to reassess and restrict or ban paraquat due to links to Parkinsons disease. The Paraquat Prevention Act (H.R. 9357): This legislation would direct EPA to cancel all registrations for the herbicide paraquat, revoke food-residue tolerances, prohibit the sale and use of existing stocks, and permanently bar re-registration, citing evidence linking paraquat exposure to an increased risk of Parkinsons disease. H.Amdt.196: An amendment to the 2026 Farm Bill (H.R. 7567, the Farm, Food, and National Security Act of 2026) that removed three pesticide-related provisions. The amendment eliminated language that would have: (1) limited certain lawsuits against pesticide manufacturers by making it more difficult to bring failure-to-warn claims based on health risks not included on EPA-approved labels; (2) restricted state and local governments from adopting pesticide requirements that exceed federal standards; and (3) modified environmental permitting and oversight requirements for pesticide use, including provisions affecting implementation of the Clean Water Act and other environmental laws. The Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), including advocacy related to early detection of Alzheimers disease and related dementias and access to diagnostic tools. The Lowering Costs for Caregivers Act (S. 1565 / H.R. 138), including advocacy related to expanding the use of tax-advantaged health accounts (including HSAs, FSAs, and HRAs) to cover medical expenses for family caregivers and improving affordability of care. The Essential Caregivers Act of 2025 (H.R. 6766 / S. 3492), including advocacy related to ensuring access for designated essential caregivers in health care facilities during periods of restricted visitation under Medicare and Medicaid.

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -End Coverage with Evidence Development for Alzheimer's medications and Trans Catheter Aortic Valve Replacement

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

-Alzheimer's Screening & Prevention Act (ASAP) H.R. 6130/ S. 3267 -Lowering Costs for Caregivers Act (S. 1565/H.R. 138) -Federal vaccine messaging -Impacts of IRA on Older Americans -National Institutes of Health advance funding of multi-year research grants -Clinical Trials Modernization Act H.R.7905 -Patient Access to Cancer and Complex Therapies Act H.R. 4299 -Diabetes Foot Health and Modernization Access Act H.R. 7905 -Oppose PBM Kickbacks H.R. 7895 -Oppose Codification of MFN Drug Pricing Proposals (no bill) -Message support for Rare Disease Clinical Trials Improvements

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 589 - FACE Act Repeal Act of 2025 All provisions This bill amends title 18, United States Code, to repeal prohibitions relating to freedom of access to clinic entrances. H.R. 3916/S. 2029 - My Body, My Data Act of 2025 All provisions This bill creates protections for the privacy of personal reproductive or sexual health information. H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025 All provisions This bill amends title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act All provisions This bill amends the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives. H.R. 4849/S. 2556 - Protecting Health Care and Lowering Costs Act of 2025 All provisions This bill will repeal health-related portions of An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, and for other purposes. H.R. 4541/S. 2339 - EARLY Act Reauthorization of 2025 All provisions. This bill reauthorizes the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025 All provisions. This bill amends title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. H.R. 6182/ S. 1410- Find It Early Act All provisions. This bill would ensure all health insurance plans cover screening and diagnostic breast imaging with no cost-sharing, including mammograms, ultrasounds and breast ultrasounds, and MRIs. H.R. 2048/S. 3442 - Metastatic Breast Cancer Access to Care Act All provisions. This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). H.R. 2381/S. 1866 - SCREENS for Cancer Act of 2025 All provisions. This bill amends the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030. H.R. 3501/S. 1799 - Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act All provisions. This bill amends title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. H.R. 6130/S. 3267 - ASAP Act All provisions. This bill amends title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. H.R. 7417/S. 3944 - Womens Heart Health Expansion Act All provisions. This bill amends the Public Health Service Act to reauthorize the WISEWOMAN program. S. 3999 - Women Veterans Specialty Care Access Act All provisions. This bill requires the Secretary of Veterans Affairs to ensure that women veterans may schedule appointments for womens specialty care under the laws administered by the Secretary without requiring a referral.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions regarding drug pricing and supply chain issues; rare diseases; Alzheimer's policy, screening and diagnosis, dementia care; ALS, Lupus and Kidney related policy issues. Issues related to patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues, no specific bill numbers. Engage on public policy associated with orphan drug act, rare disease research, screening, detection and patient access for rare therapies. Public Policy efforts around Alzheimer's screening and diagnosis Public policy around patients access and affordability for necessary and life-saving medications prescribed by their doctors. S.864, HELP Copays Act, to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-share H.R.6130/S.3267, ASAP Act, to provide coverage for blood based biomarker Alzheimer's disease diagnosis H.R.3747, AADAPT Act, to provide for training for primary care for screening, detection and diagnosis for Alzheimer's disease Issues related to the Food and Drug Administration including PDUFA, druga reviews, approval pathways, and clinical trials H.R.1262, Mikaela Naylon Give Kids a Chance Act, reauthorization of FDA Pediatric-Priority Review Voucher Program Postpartum Depression public policy on screening, detection and education

Client expense: $1,460,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE